Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)

por Krikmann, Ülle, Taba, Pille, Lai, Taavi, Asser, Toomas
Publicado 2008

Factors associated with motor complications in Parkinson's disease

por Kadastik‐Eerme, Liis, Taba, Nele, Asser, Toomas, Taba, Pille
Publicado 2017

Aneurysmal subarachnoid haemorrhage: Effect of CRHR1 genotype on mental health-related quality of life

por Vetkas, Artur, Prans, Ele, Kõks, Sulev, Rätsep, Tõnu, Asser, Toomas
Publicado 2020

Aneurysmal subarachnoid haemorrhage: effect of CRHR1 genotype on fatigue and depression

por Vetkas, Artur, Prans, Ele, Kõks, Sulev, Rätsep, Tõnu, Asser, Toomas
Publicado 2020

The Effect of Functional Electrical Stimulation and Therapeutic Exercises on Trunk Muscle Tone and Dynamic Sitting Balance in Persons with Chronic Spinal Cord Injury: A Crossover T...

por Bergmann, Margot, Zahharova, Anna, Reinvee, Märt, Asser, Toomas, Gapeyeva, Helena, Vahtrik, Doris
Publicado 2019

Single session exercises and concurrent functional electrical stimulation are more effective on muscles’ force generation than only exercises in spinal cord injured persons: a feas...

por Bergmann, Margot, Zahharova, Anna, Ereline, Jaan, Asser, Toomas, Gapeyeva, Helena, Vahtrik, Doris
Publicado 2020

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme

por Kase, Marju, Minajeva, Ave, Niinepuu, Kristi, Kase, Sandra, Vardja, Markus, Asser, Toomas, Jaal, Jana
Publicado 2013

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients

por Minajeva, Ave, Kase, Marju, Saretok, Mikk, Adamson-Raieste, Aidi, Kase, Sandra, Niinepuu, Kristi, Vardja, Markus, Asser, Toomas, Jaal, Jana
Publicado 2017

Tumor-penetrating peptide for systemic targeting of Tenascin-C

por Lingasamy, Prakash, Tobi, Allan, Kurm, Kaarel, Kopanchuk, Sergei, Sudakov, Aleksander, Salumäe, Markko, Rätsep, Tõnu, Asser, Toomas, Bjerkvig, Rolf, Teesalu, Tambet
Publicado 2020

VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment

por Jaal, Jana, Kase, Marju, Minajeva, Ave, Saretok, Mikk, Adamson, Aidi, Junninen, Jelizaveta, Metsaots, Tõnis, Jõgi, Tõnu, Joonsalu, Madis, Vardja, Markus, Asser, Toomas
Publicado 2015

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

por Shakur, Haleema, Andrews, Peter, Asser, Toomas, Balica, Laura, Boeriu, Cristian, Quintero, Juan Diego Ciro, Dewan, Yashbir, Druwé, Patrick, Fletcher, Olivia, Frost, Chris, Hartzenberg, Bennie, Mantilla, Jorge Mejia, Murillo-Cabezas, Francisco, Pachl, Jan, Ravi, Ramalingam R, Rätsep, Indrek, Sampaio, Cristina, Singh, Manmohan, Svoboda, Petr, Roberts, Ian
Publicado 2009